Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
China · Delayed Price · Currency is CNY 7.13
+0.08 (1.13%)
Jan 23, 2026, 3:04 PM CST
Guangdong VTR Bio-Tech Revenue
Guangdong VTR Bio-Tech had revenue of 198.11M CNY in the quarter ending September 30, 2025, a decrease of -6.21%. This brings the company's revenue in the last twelve months to 830.87M, up 3.46% year-over-year. In the year 2024, Guangdong VTR Bio-Tech had annual revenue of 826.20M with 3.79% growth.
Revenue (ttm)
830.87M
Revenue Growth
+3.46%
P/S Ratio
4.12
Revenue / Employee
753.96K
Employees
1,102
Market Cap
3.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 826.20M | 30.18M | 3.79% |
| Dec 31, 2023 | 796.02M | -377.98M | -32.20% |
| Jan 1, 2023 | 1.17B | -718.15M | -37.95% |
| Jan 1, 2022 | 1.89B | -22.60M | -1.18% |
| Dec 31, 2020 | 1.91B | -133.37M | -6.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.69B |
| Qingdao Vland Biotech INC. | 1.39B |
| Shandong Sito Bio-technology | 954.76M |
| Cabio Biotech (Wuhan) | 596.47M |
| Suzhou Fushilai Pharmaceutical | 439.57M |
| Shanghai Model Organisms Center | 419.09M |
| Yantai Zhenghai Biotechnology | 347.60M |
| Shanghai Shen Lian Biomedical | 292.81M |